Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2026Diabetology & Metabolic SyndromeOpen Access

Incident ocular outcomes with tirzepatide versus GLP-1 receptor agonists and conventional therapies in diabetes and obesity: a retrospective cohort study from a global federated health research network

View Full Paper
Ask AI
Bookmark
Share

Authors

NTNguyen Ngoc Khoi TruongCLChia‐Te LiaoCCChih-Wei Chen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Truong et al. (2026) studied this question.

synapsesocial.com/papers/6ab60ecf406bf401c14675d5https://doi.org/10.1186/s13098-026-02299-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists2025 · 28 citations
  2. 2Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon‐Like Peptide‐1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease2026 · 1 citations
  3. 3Incident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes2026
  4. 4Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study2026
  5. 5Cardiovascular Outcomes With Tirzepatide Versus <scp>GLP</scp> ‐1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta‐Analysis2026 · 1 citations